Gelteq Limited Ordinary Shares (GELS)vsTeva Pharma Industries Ltd ADR (TEVA)
GELS
Gelteq Limited Ordinary Shares
$0.57
-1.67%
HEALTHCARE · Cap: $5.97M
TEVA
Teva Pharma Industries Ltd ADR
$37.92
-0.79%
HEALTHCARE · Cap: $44.19B
Smart Verdict
WallStSmart Research — data-driven comparison
Teva Pharma Industries Ltd ADR generates 3669887% more annual revenue ($17.32B vs $471,800). TEVA leads profitability with a 4.1% profit margin vs 0.0%. TEVA earns a higher WallStSmart Score of 47/100 (D+).
GELS
Avoid33
out of 100
Grade: F
TEVA
Hold47
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 48.9% year-over-year
Earnings expanding 72.2% YoY
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -24.9% — below average capital efficiency
4.1% margin — thin
Operating margin of 4.0%
Premium valuation, high expectations priced in
Revenue declined 0.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : GELS
The strongest argument for GELS centers on Price/Book, Revenue Growth. Revenue growth of 48.9% demonstrates continued momentum.
Bull Case : TEVA
The strongest argument for TEVA centers on EPS Growth. PEG of 1.04 suggests the stock is reasonably priced for its growth.
Bear Case : GELS
The primary concerns for GELS are EPS Growth, Market Cap, Profit Margin.
Bear Case : TEVA
The primary concerns for TEVA are Profit Margin, Operating Margin, P/E Ratio. A P/E of 63.2x leaves little room for execution misses. Debt-to-equity of 2.18 is elevated, increasing financial risk.
Key Dynamics to Monitor
GELS profiles as a hypergrowth stock while TEVA is a value play — different risk/reward profiles.
GELS is growing revenue faster at 48.9% — sustainability is the question.
TEVA generates stronger free cash flow (307M), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - SPECIALTY & GENERIC industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TEVA scores higher overall (47/100 vs 33/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Gelteq Limited Ordinary Shares
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. The company is headquartered in Caulfield, Australia.
Visit Website →Teva Pharma Industries Ltd ADR
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.
Compare with Other DRUG MANUFACTURERS - SPECIALTY & GENERIC Stocks
Want to dig deeper into these stocks?